Cite
HARVARD Citation
Nguyen, H. et al. (2019). Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden. Neuro-oncology practice. 6 (2), pp. 103-111. [Online].